Proton Beam Therapy Research

Fanconi Hope is currently fundraising for further research, in particular for ground-breaking Proton Beam Therapy research aimed at improving the treatment of the ‘difficult cancers’ that affect so many people living with Fanconi Anaemia.

The first UK Proton Beam Therapy facility is in the final stages of commissioning at the Christie Proton Therapy Centre in Manchester and our Study Proposal has the support of the Clinical Director of the Centre, who says “It is very likely that patients with DNA damage response defects, such as Fanconi anaemia, would be considered eligible for treatment with proton therapy (should they require radiation therapy for cancer), with the aim of lessening the risk of side effects. The more we know about the biology of proton-induced damage in these tissues, the sooner we will be able to translate findings into the clinic and influence future treatment strategies with proton therapy in this group of patients”.

Share this page